Tractor industry may clock 9-10% growth in FY17: ICRA
This, keeping in mind the impact of demonetisation over the near term14-12-2016
Tractor industry may clock 9-10% growth in FY17: ICRA
This, keeping in mind the impact of demonetisation over the near termIndian pharma industry facing growth headwinds: ICRA
Indian pharmaceutical industry will grow at a slower pace due to sluggish growth in the US market, increased competition leading to price erosion in high single digits and generic adoption reaching saturation levels, rating agency ICRA said today.Demonetisation augurs challenging times for Indian steel players: ICRA
Anticipated slowdown in real-estate sector following demonetisation will impact steel demand in immediate termICRA: new emission norms for thermal projects will turn power costlier
New plants will have to comply immediately, older plants given time till Dec 2017Updates
ICRA Ltd has submitted to BSE copies of the Notice for attention of the shareholders of the Company, in respect of transfer of equity shares to the Investor Education and Protection Fund Suspense Account published in the newspapers on November 25, 2016.InvITs May Raise Rs 20,000 Crore Over Next 18 Months: ICRA
Infra investment trusts or commonly known as InvITsare collective investment vehicles which make investments ininfra projects either directly or through SPVs.High Value Note Demonetisation: ICRA Lowers Growth Forecast
ICRA expects growth of Indian gross value added (GVA) at basic prices to print at 7.2 per cent in second quarter of 2016-17, mildly lower than the year-ago period.Mills will be profitable despite rise in state advised price for sugarcane in UP: ICRA
Last week, the UP government announced a Rs 25 per quintal increase in SAP of sugarcane for the sugar year (SY) 2016-17 (October-September season).Two-Wheelers Sales To Be Affected By Demonetisation: ICRA
Rural markets account for about 60-65 per cent of the entry segment motorcycle sales.Analyst Presentation (Q2 FY17)
ICRA Ltd has informed BSE regarding "Submission of Analyst Presentation (Q2 FY17)".